James E Robinson

Title: Innovations of James E Robinson in Arenavirus Research

Introduction

James E Robinson is a notable inventor based in New Orleans, LA, with a significant contribution to the field of virology. He holds a total of seven patents, primarily focused on the development of monoclonal antibodies targeting arenaviruses. His work has implications for therapeutic and preventative measures against various strains of these viruses.

Latest Patents

Among his latest patents are compositions comprising recombinant arenavirus monoclonal antibodies and antigen-binding fragments. These antibodies are designed to provide pan-arenavirus protection against multiple types and strains. Additionally, he has developed arenavirus monoclonal antibodies that serve therapeutic, diagnostic, and preventative purposes. His innovations include methods for preparing vaccines and factors that inhibit the infectivity of Old World arenaviruses, such as Lassa virus (LASV) and Lymphocytic choriomeningitis virus (LCMV). His patents also encompass diagnostic and therapeutic antibodies, including neutralizing antibodies for the prevention and treatment of infections caused by LASV and other arenaviruses.

Career Highlights

James E Robinson has worked at Cedars-Sinai Medical Center, where he has contributed to groundbreaking research in the field of infectious diseases. His career is marked by a commitment to advancing the understanding and treatment of arenavirus infections.

Collaborations

Throughout his career, Robinson has collaborated with esteemed colleagues, including David D Ho and Robert F Garry. These partnerships have further enhanced the impact of his research and innovations.

Conclusion

James E Robinson's contributions to the field of virology, particularly in the development of monoclonal antibodies against arenaviruses, highlight his role as a significant inventor. His work continues to pave the way for advancements in therapeutic and preventative measures against viral infections.